Publication | Closed Access

Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis

HepatologyLiver PhysiologyPharmacologyHepatitisComplications Of CirrhosisHepatology InflammationHepatotoxicityPharmacotherapyLiver DiseaseHepatology FibrosisMedicineDrug-induced Liver InjuryDecompensated Liver Cirrhosis